期刊文献+

健择与顺铂结合体外射频热疗治疗恶性胆系肿瘤的临床观察 被引量:1

下载PDF
导出
摘要 目的评价健择与顺铂结合体外射频热疗治疗恶性胆系肿瘤的疗效。方法44例恶性胆系肿瘤患者,分成观察组和对照组。对照组采用吡柔比星联合腹腔灌注顺铂治疗。观察组采用健择与腹腔灌注顺铂结合体外射频热疗。结果观察组有效率为36.36%(8/22)优于对照组有效率9.09%(2/22),差异具有统计学意义(P〈0.05)。结论健择与顺铂结合体外射频热疗治疗恶性胆系肿瘤患者疗效可靠,毒副作用小。
作者 龚海健
出处 《医学信息》 2011年第5期1225-1226,共2页 Journal of Medical Information
  • 相关文献

参考文献8

  • 1闫敏,宋三泰,江泽飞,张少华,刘晓晴,徐建明,王涛,罗卫东.乳腺癌骨转移内分泌治疗与化疗的对比研究[J].中华肿瘤杂志,2004,26(3):177-180. 被引量:23
  • 2郝春芳,江泽飞,宋三泰,刘晓晴,王涛,申戈,张志强,秦燕.来曲唑治疗晚期乳腺癌的临床观察[J].肿瘤研究与临床,2004,16(2):100-102. 被引量:12
  • 3Van-DER-ZEE J, GONZALEZ-GONZALEZ D, Van-RHOON G C,et al. Comparison of radiotherapy alonewith radiotherapy plus hyperthermia in locally advanced pelvic tumours : a prospective, randomised,multieentre tria.1 DutchDeepHyperthermiaGroup[J]. Lancet, 2000,355(9210): 1119-1125.
  • 4WESSALOWSKIR, Van-HEEK-ROMANOWSKIR, ISSELS R D,et al. Estimated number of children with cancer eligible for hyperthermia based on population-and treatment-related criteria [J]. Int JHyperthermia, 1999, 15 (6): 455-466.
  • 5HUANG X F, REN W, ROLLINS L,et al. A broadly applicable,personalized heat shock protein-mediated oncolytic tumorvaccine [J].CancerRes, 2003, 63 (21): 7321-7329.
  • 6谭冬梅.健择注射液治疗恶性肿瘤的观察与护理[J].中国现代医药杂志,2006,8(7):121-121. 被引量:2
  • 7马院玲,王彩萍,雷晓红.健择治疗恶性肿瘤的护理体会[J].延安大学学报(医学科学版),2009,7(4). 被引量:1
  • 8CASTROM P. Efficacy ofgemcitabine in the treatmentofpatientswith gallbladder carcinoma: a case report[J]. Cancer, 1998, 82(4): 639-641.

二级参考文献17

  • 1廖美琳,李龙芸,万欢英,徐农,刘基巍,梁后杰,王莉.吉西他滨联合顺铂3周方案治疗晚期非小细胞肺癌患者的临床受益分析——前瞻性观察性研究[J].中国癌症杂志,2004,14(6):523-526. 被引量:7
  • 2宋三泰.乳癌内分泌治疗应该注意的几个问题[J].中国实用外科杂志,1997,17(2):70-72. 被引量:6
  • 3Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer, 2000,7: 271-284.
  • 4Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer, 1981,47 : 207-214.
  • 5Hortobagyi GN. Novel approaches to the management of bone metastases in patients with breast cancer. Semin Oncol, 2002, 29:134-144.
  • 6Mouridsen H, Gershanovich M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase Ⅲ study of the International Letrozole Breast Cancer Group. J Clin Oncol, 2001,19:2596-2606.
  • 7Robertson J, Howell A, Buzdar A, et al. Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer. Breast Cancer Res Treat, 1999,58: 157-162.
  • 8Mouridsen H, C, ershanovich M, Sun Y, et al. Superior eefficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:, results of a phase Ⅲ study of the international letrozole breast cancer group [J].
  • 9Robertson J, Buzdar A, Howell A, et al. Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer[J]. Breast Cancer Res Treat, 1999,58 (2):157-162.
  • 10Dombemowsky P, Smith I, Falkson G, et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate[J]. J Clin Oncol, 19

共引文献29

同被引文献9

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部